1-20 of 47
Michael Leblanc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study

Free
Nancy Bartlett, Hongli Li, Michael Knopp, Chad Wright, Heiko Schoder, Lawrence Schwartz, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Angela Punnett, Margaret Shipp, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Lale Kostakoglu, Kara Kelly, Michael LeBlanc, Jonathan Friedberg, Alex Herrera
Journal: Blood
Blood (2025) 146 (Supplement 1): 1851.
https://doi.org/10.1182/blood-2025-1851
Published: 2025
Journal Articles

The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)

Free
Kelly Davison, Joseph Unger, Hongli Li, Sharon Castellino, Hildy Dillon, Tricia Hernandez, Sarah Rutherford, Angela Punnett, Michael LeBlanc, Joo Song, Sonali Smith, Andrew Evens, Kara Kelly, Jonathan Friedberg, Alex Herrera, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 2738.
https://doi.org/10.1182/blood-2025-2738
Published: 2025
Journal Articles

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Free
Julia Paczkowska, Marcin Kaszkowiak, Michael Leblanc, Chip Stewart, Alex Herrera, Juan Carlos Fernandez del Castillo, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Hongli Li, Donna Neuberg, Mark Murakami, Jasmine Makker, Brad Kahl, John Leonard, Nancy Bartlett, Sonali Smith, Joo Song, Kara Kelly, Gad Getz, Jonathan Friedberg, Margaret Shipp
Journal: Blood
Blood (2025) 146 (Supplement 1): 351.
https://doi.org/10.1182/blood-2025-351
Published: 2025
Journal Articles

Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)

Free
Carla Casulo, Hongli Li, Alex Herrera, Sharon Castellino, Sarah Rutherford, Kelly Davison, Angela Punnett, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg, Michael Leblanc, Susan Parsons, Angie Mae Rodday, Andrew Evens
Journal: Blood
Blood (2025) 146 (Supplement 1): 154.
https://doi.org/10.1182/blood-2025-154
Published: 2025
Journal Articles

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Free
Alex Herrera, Michael Leblanc, Sharon Castellino, Hongli Li, Sarah Rutherford, Andrew Evens, Kelly Davison, Susan Parsons, Sairah Ahmed, Carla Casulo, Nancy Bartlett, Joseph Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Boyu Hu, Craig Moskowitz, Christopher Forlenza, Andrew Doan, Adam Lamble, David Hodgson, Anca Prica, Michael Knopp, Tricia Hernandez, Richard Little, Margaret Shipp, Michael Crump, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg
Journal: Blood
Blood (2025) 146 (Supplement 1): 151.
https://doi.org/10.1182/blood-2025-151
Published: 2025
Journal Articles

S2207: Randomized Phase II Study of the Addition of Targeted Agents to Tafasitamab-Lenalidomide in Transplant Ineligible Patients with Relapsed/Refractory LBCL

Free
Jennifer E. Amengual, Hongli Li, Patrick M. Reagan, Tareq Al Baghdadi, Hayder Saeed, Joseph M Unger, Alexey Danilov, Michael Leblanc, Jonathan W. Friedberg, Sonali M. Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 3123.2.
https://doi.org/10.1182/blood-2024-199784
Published: 2024
Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Free
Sarah C. Rutherford, Hongli Li, Alex F. Herrera, Michael Leblanc, Sairah Ahmed, Kelly L. Davison, Carla Casulo, Nancy L. Bartlett, Joseph M Tuscano, Brian Hess, Pallawi Torka, Pankaj Kumar, Ryan W Jacobs, Joo Y Song, Sharon M. Castellino, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Jonathan W. Friedberg, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 181.
https://doi.org/10.1182/blood-2023-180114
Published: 2023
Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Free
Sharon M. Castellino, Hongli Li, Alex F. Herrera, Angela Punnett, Michael Leblanc, Susan K Parsons, David Hodgson, Frank Keller, Richard A. Drachtman, Adam Lamble, Christopher J. Forlenza, Andrew Doan, Sarah C. Rutherford, Andrew M Evens, Richard F. Little, Malcolm A. Smith, Joo Y Song, Sonali M. Smith, Jonathan W. Friedberg, Kara M. Kelly
Journal: Blood
Blood (2023) 142 (Supplement 1): 610.
https://doi.org/10.1182/blood-2023-180107
Published: 2023
Journal Articles

Minimal Residual Disease (MRD) Status Predicts Outcomes in Patients with Follicular Lymphoma (FL) Treated with Chemo-Immunotherapy on SWOG S0016

Free
Alexey Danilov, Hongli Li, Mazyar Shadman, Lisa M. Rimsza, Ahmad Zebari, Sonali M. Smith, Michael Leblanc, Jonathan W. Friedberg, Christopher Carlson, Joo Y Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 4359.
https://doi.org/10.1182/blood-2023-179612
Published: 2023
Journal Articles

Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma

Free
Deborah M. Stephens, Hongli Li, Heiko Schöder, David J. Straus, Craig H. Moskowitz, Michael LeBlanc, Lisa M. Rimsza, Nancy L. Bartlett, Andrew M. Evens, Ann S. LaCasce, Paul M. Barr, Michael V. Knopp, Eric D. Hsi, John P. Leonard, Brad S. Kahl, Sonali M. Smith, Jonathan W. Friedberg
Journal: Blood
Blood (2019) 134 (15): 1238–1246.
https://doi.org/10.1182/blood.2019000719
Published: 2019
Includes: Supplemental data
Journal Articles

Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study

Free
Clinical Trials & Observations Brief Report
Eric D. Hsi, Hongli Li, Andrew B. Nixon, Heiko Schöder, Nancy L. Bartlett, Michael LeBlanc, Sonali Smith, Brad S. Kahl, John P. Leonard, Andrew M. Evens, David W. Scott, Lisa M. Rimsza, Jonathan W. Friedberg
Journal: Blood
Blood (2019) 133 (16): 1762–1765.
https://doi.org/10.1182/blood-2018-08-870915
Published: 2019
Includes: Supplemental data
Journal Articles

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016

Free
Clinical Trials & Observations
Xiaoyu Qu, Hongli Li, Rita M. Braziel, Verena Passerini, Lisa M. Rimsza, Eric D. Hsi, John P. Leonard, Sonali M. Smith, Robert Kridel, Oliver Press, Oliver Weigert, Michael LeBlanc, Jonathan W. Friedberg, Min Fang
Journal: Blood
Blood (2019) 133 (1): 81–93.
https://doi.org/10.1182/blood-2018-07-865428
Published: 2019
Includes: Supplemental data
Journal Articles

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Free
Patrick J. Stiff, MD, Hongli Li, PhD, James R. Cook, MD PhD, Louis S. Constine, MD, Stephen Couban, MD, Douglas A. Stewart, MD FRCPC, Thomas C. Shea, MD, Pierluigi Porcu, MD, Jane N. Winter, MD, Brad S Kahl, Sonali M. Smith, MD, Deborah Marcellus, MD, Kevin Barton, MD, Glenn M. Mills, MD, Michael LeBlanc, PhD, Lisa Rimsza, MD, Stephen J. Forman, MD, John P. Leonard, MD, Richard I. Fisher, MD, Jonathan Friedberg, MD
Journal: Blood
Blood (2016) 128 (22): 4651.
https://doi.org/10.1182/blood.V128.22.4651.4651
Published: 2016
Journal Articles

Sequential RCHOP, Radioimmunotherapy and Rituximab Maintenance Improves Early Outcomes in Advanced Stage Follicular Lymphoma: 5 Year Outcomes from SWOG 0801

Free
Paul M. Barr, Hongli Li, PhD, Richard Burack, MD PhD, Michael LeBlanc, PhD, Sonali M. Smith, MD, Ajay K. Gopal, MD, Justin D. Floyd, DO, Daniel O. Persky, MD, Oliver Press, MD PhD, Richard I. Fisher, MD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2016) 128 (22): 614.
https://doi.org/10.1182/blood.V128.22.614.614
Published: 2016
Journal Articles

Continued Excellent Outcomes in Previously Untreated Follicular Lymphoma Patients after Treatment with CHOP Plus Rituximab or CHOP Plus (131) Iodine-Tositumomab - Long Term Follow-up of Phase III Randomized Study SWOG S0016

Free
Mazyar Shadman, MD MPH, Hongli Li, PhD, Lisa Rimsza, MD, John P. Leonard, MD, Mark S Kaminski, MD, Rita M Braziel, MD, Catherine M. Spier, MD, Ajay K Gopal, MD, David G Maloney, MD PhD, Bruce Cheson, MD, Shaker Dakhil, MD FACP, Michael LeBlanc, PhD, Sonali M. Smith, MD, Richard I. Fisher, MD, Jonathan W. Friedberg, MD, Oliver Press, MD PhD
Journal: Blood
Blood (2016) 128 (22): 616.
https://doi.org/10.1182/blood.V128.22.616.616
Published: 2016
Journal Articles

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Free
Xiaoyu Qu, PhD, Hongli Li, PhD, Oliver W Press, MD PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Michael Leblanc, PhD, Eric D. Hsi, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc, Min Fang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2678.
https://doi.org/10.1182/blood.V126.23.2678.2678
Published: 2015
Journal Articles

A Phase I/II Trial of Vorinostat (SAHA) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG S0806

Free
Daniel O. Persky, MD, Hongli Li, PhD, Lisa M. Rimsza, MD, Paul M. Barr, MD, Leslie L. Popplewell, MD, Charles L. Bane, MD, Ann Von Gehr, MD, Michael Leblanc, PhD, Richard I. Fisher, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 3931.
https://doi.org/10.1182/blood.V126.23.3931.3931
Published: 2015
Journal Articles

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Free
Robert Chen, Hongli Li, PhD, Steven H. Bernstein, MD, Lisa M. Rimsza, MD, Stephen J. Forman, MD, Louis Constine, MD, Thomas C. Shea, MD, Amanda F. Cashen, MD, Kristie A. Blum, MD, Timothy S. Fenske, MD, Paul M. Barr, MD, Michael Leblanc, PhD, Richard I. Fisher, MD, Bruce D. Cheson, MD, Sonali M. Smith, MD, Malek Faham, Jennifer Wilkins, John P. Leonard, MD, Brad S. Kahl, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 518.
https://doi.org/10.1182/blood.V126.23.518.518
Published: 2015
Journal Articles

Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma

Free
Muhammad A. Mir, Matthew J. Maurer, Steven C. Ziesmer, Susan L. Slager, Thomas Habermann, William R. Macon, Brian K. Link, Sergei Syrbu, Thomas Witzig, Jonathan W. Friedberg, Oliver Press, Michael LeBlanc, James R. Cerhan, Anne Novak, Stephen M. Ansell
Journal: Blood
Blood (2015) 125 (6): 992–998.
https://doi.org/10.1182/blood-2014-06-583369
Published: 2015
Includes: Supplemental data
Journal Articles

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313

Free
Clinical Trials & Observations
Daniel O. Persky, Thomas P. Miller, Joseph M. Unger, Catherine M. Spier, Soham Puvvada, B. Dino Stea, Oliver W. Press, Louis S. Constine, Kevin P. Barton, Jonathan W. Friedberg, Michael LeBlanc, Richard I. Fisher
Journal: Blood
Blood (2015) 125 (2): 236–241.
https://doi.org/10.1182/blood-2014-06-584623
Published: 2015